Sentinel lymph node biopsy after neoadjuvant chemotherapy

Breast Cancer

Volumn 11, Issue 3, 2004, Pages 233-241

  Kang, Seek Hyung ^a   Kang, Jae Hee ^a   Chow, Eun A ^b   Lee, Eun Soak ^a  

^a National Cancer Center   (South Korea)

^b Dongguk University College of Medicine   (South Korea)

Author keywords

Axillary lymph node dissection; Breast cancer; Neoadjuvant chemotherapy; Sentinel lymph node biopsy

Indexed keywords

ADJUVANT THERAPY; ADULT; AGE; AGED; BREAST; BREAST TUMOR; CANCER STAGING; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; REVIEW; SENTINEL LYMPH NODE BIOPSY; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; BREAST; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGAN SIZE; SENTINEL LYMPH NODE BIOPSY;

EID: 16644374957     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02984543     Document Type: Review

References (56)

1. Fisher ER, Wang J, Bryant J, et al: Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18. Cancer 95:681-695, 2002. (Pubitemid 34845919)
2. Kuerer HM, Sahin AA, Hunt KK, et al: Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230:72-78, 1999. (Pubitemid 30190367)
3. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:3628-3636, 2002. (Pubitemid 34983222)
4. Nason KS, Anderson BO, Byrd DR, et al: Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer 89:2187-2194, 2000.
5. Miller AR, Thomason VE, Yeh IT, et al: Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma. Ann Surg Oncol 9:243-247, 2002. (Pubitemid 34298628)
6. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.J Clin Oncol 15:2483-2493, 1997. (Pubitemid 27289876)
7. Breslin TM, Cohen L, Sahin A, et al: Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18:3480-3486, 2000.
8. Cohen LF, Breslin TM, Kuerer HM, et al: Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 24:1266-1272, 2000.
9. Tafra L, Verbanac KM, Lannin DR: Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 182:312-315, 2001. (Pubitemid 33079077)
10. Hald A, Tausch C, Lang A, et al: Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Cancer 92:1080-1084, 2001. (Pubitemid 32861654)
11. Julian TB, Patel N, Dusi D, et al: Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 182:407-410, 2001. (Pubitemid 33079097)
12. Brady EW: Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 8:97-100, 2002. (Pubitemid 34233588)
13. Stearns V, Ewing CA, Slack R, et al: Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9:235-242, 2002. (Pubitemid 34298627)
14. Reitsamer R, Peintinger F, Rettenbacher L, et al: Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. ] Surg Oncol 84:63-67, 2003. (Pubitemid 37247910)
15. Balch GC, Mithani SK, Richards KIL et al: Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage lI and Ill breast cancer. Ann Surg Oncol 10:616-621, 2003. (Pubitemid 40486892)
16. Piato JR, Barros AC, Pincerato KM, et al: Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Onco129:118-120, 2003. (Pubitemid 36367342)
17. Schwartz GF, Meltzer AJ: Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 9:374-379, 2003. (Pubitemid 37158910)
18. Fernandez A, Cortes M, Benito E, et al: Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 22:361-366, 2001. (Pubitemid 32291650)
19. Vigario A, Sapienza MT, Sampaio AP, et al: Primary chemotherapy effect in sentinel node detection in breast cancer. Clin Nucl Med 28:553-557, 2003. (Pubitemid 38281919)
20. Mamounas EP: Sentinel lymph node biopsy after neoadjuvant systemic therapy. Surg Clin North Am 83:931-942, 2003. (Pubitemid 36841917)
21. Temple LK, Baron R, Cody HS 3rd, et al: Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9:654-662, 2002. (Pubitemid 34857982)
22. Burak WE, Hollenbeck ST, Zervos EE, et al: Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23-27, 2002. (Pubitemid 34178601)
23. Schrenk P, Rieger R, Shamiyeh A, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000. (Pubitemid 30056936)
24. Warmuth MA, Bowen G, Prosnitz LR, et al: Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 83:1362-1368, 1998. (Pubitemid 28460087)
25. Singletary SE: Neoadjuvant chemotherapy in the treatment of stage lI and Ill breast cancer. Am J Surg 182:341-346, 2001. (Pubitemid 33079083)
26. Mansour EG, Gray R, Shatila AH, et al: Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med 320:485-490, 1989. (Pubitemid 19062523)
27. Fisher B, Costantino J, Redmond C, et al: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320:479-484, 1989. (Pubitemid 19062522)
28. Fisher B, Redmond C, Dimitrov NV, et al: A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with nodenegative breast cancer who have estrogen-receptornegative tumors. N EngI J Med 320:473-478, 1989. (Pubitemid 19062521)
29. Allweis TM, Badriyyah M, Ad VB, et al: Current controversies in sentinel lymph node biopsy for breast cancer. The Breast 12:163-171, 2003. (Pubitemid 36665513)
30. Giuliano AE, Haigh PI, Brennan MB, et al: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18:2553-2559, 2000. (Pubitemid 30432521)
31. Kelly MR, Kerin MJ: The value of axillary lymphadenectomy. Eur J Surg Onco129:701-702, 2003. (Pubitemid 37483939)
32. Ponzone R, Biglia N, Maggiorotto F, et al: Sentinel node dissection as definitive treatment for node negative breast cancer patients. Eur J Surg Oncol 29:703-706, 2003. (Pubitemid 37483940)
33. Krag D, Weaver D, Ashikaga T, et al: The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 339:941-946, 1998. (Pubitemid 28455095)
34. Miltenburg DM, Miller C, Karamlou TB, et al: Metaanalysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84:138-142, 1999. (Pubitemid 29389989)
35. Cox CE, Bass SS, McCann CR, et al: Lymphatic mapping and sentinel lymph node biopsy in patients with breast cancer. Annu Rev Med 51:525-542, 2000. (Pubitemid 30216053)
36. Bedrosian I, Reynolds C, Mick R, et al: Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88:2540-2545, 2000. (Pubitemid 30331961)
37. McMasters KM, Tuttle TM, Carlson D J, et al: Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Onco118:2560-2566, 2000. (Pubitemid 30432522)
38. Cody HS 3rd, Fey J, Akhurst T, et al: Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures. Ann Surg Oncol 8:13-19, 2001. (Pubitemid 32126820)
39. Noguchi M: Sentinel lymph node biopsy and breast cancer. Br J Surg 89:21-34, 2002. (Pubitemid 34031303)
40. Tuttle TM, Zogakis TG, Dunst CM, et al: A review of technical aspects of sentinel lymph node identification for breast cancer. J Am Coll Surg 195:261-268, 2002. (Pubitemid 34832686)
41. Giuliano AE, Kirgan DM, Guenther JM, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398; discussion 398-401, 1994.
42. Tafra L, Lannin DR, Swanson MS, et al: Mulficenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233:51-59, 2001. (Pubitemid 32042775)
43. McMasters KM, Wong SL, Martin RC 2nd, et al: Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 233:676-687, 2001. (Pubitemid 32378652)
44. Bass SS, Cox CE, Ku NN, et al: The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 189:183-194, 1999. (Pubitemid 29364692)
45. Borgstein PJ, Pijpers R, Comans EF, et al: Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.JAm Coll Surg 186:275-283, 1998. (Pubitemid 28124433)
46. Giuliano AE, Jones RC, Brennan M, et al: Sentinel lymphadenectomy in breast cancer. J Clin Oncol 15:2345-2350, 1997. (Pubitemid 27251137)
47. Fraile M, Rull M, Julian FJ, et al: Sentinel node biopsy as a practical alternative to axillary lymph node dissection in breast cancer patients: an approach to its validity. Ann Oncol 11:701-705, 2000.
48. Noguchi M, Motomura K, Imoto S, et al: A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63:31-40, 2000.
49. Chung MH, Ye W, Giuliano AE: Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer. Ann Surg Oncol 8:688-692, 2001. (Pubitemid 32952482)
50. Wong SL, Edwards M J, Chao C, et al: The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol 9:272-277, 2002. (Pubitemid 34298632)
51. Haigh PI, Hansen NM, Qi K, et al: Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer. Ann Surg Oncol 7:21-27, 2000. (Pubitemid 30078489)
52. Sachdev U, Murphy K, Derzie A, et al: Predictors of nonsentinel lymph node metastasis in breast cancer patients. Am J Surg 183:213-217, 2002. (Pubitemid 34273972)
53. Honkoop AH, Pinedo HM, De Jong JS, et al: Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 107:211-218, 1997. (Pubitemid 27098173)
54. Sneige N, Kemp B, Pusztai L, et al: Chemotherapyinduced histologic changes in mastectomy specimens and their potential significance. Breast 10:492-500, 2001. (Pubitemid 33150364)
55. Moll UM, Chumas J: Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer. Pathol Res Praet 193:187-196, 1997. (Pubitemid 27399710)
56. Schwartz GF, Giuliano AE, Veronesi U: Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 94:2542-2551, 2002. (Pubitemid 34478066)